Hepatitis C virus infection and kidney transplantation in 2014: what's new? (Q38236820)

31 August 2017

title

Hepatitis C virus infection and kidney transplantation in 2014: what's new? (English)

1 reference

31 August 2017

1 reference

1 reference

kidney transplantation

1 reference

D Moradpour

3

0 references

author name string

S Baid-Agrawal

1

1 reference

31 August 2017

M Pascual

2

1 reference

31 August 2017

R Somasundaram

4

1 reference

31 August 2017

M Muche

5

1 reference

31 August 2017

language of work or name

English

0 references

publication date

4 August 2014

1 reference

American Journal of Transplantation

31 August 2017

published in

1 reference

31 August 2017

volume

14

1 reference

31 August 2017

issue

10

1 reference

31 August 2017

page(s)

2206-2220

1 reference

Hepatitis C virus infection in haemodialysis and kidney transplant patients

31 August 2017

cites work

1 reference

The global health burden of hepatitis C virus infection

21 January 2018

1 reference

Chronic hepatitis C virus (HCV) disease burden and cost in the United States

21 January 2018

1 reference

Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of German data

21 January 2018

1 reference

Impact of hepatitis B and C virus infections on kidney transplantation: a single center experience

21 January 2018

1 reference

Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand

21 January 2018

1 reference

High false-negative rate of anti-HCV among Egyptian patients on regular hemodialysis

21 January 2018

1 reference

Occult hepatitis C: how convincing are the current data?

21 January 2018

1 reference

Occult Hepatitis C Virus Infection among Hemodialysis Patients

21 January 2018

1 reference

No evidence of occult hepatitis C virus (HCV) infection in serum of HCV antibody-positive HCV RNA-negative kidney-transplant patients

21 January 2018

1 reference

Successful treatment of chronic HCV infection should not preclude kidney donation to an HCV negative recipient.

21 January 2018

1 reference

Prevalence of occult hepatitis C infection in chronic hemodialysis and kidney transplant patients.

21 January 2018

1 reference

Accuracy of ultrasound to identify chronic liver disease.

21 January 2018

1 reference

Effect of kidney transplantation on outcomes among patients with hepatitis C

21 January 2018

1 reference

Selection and management of hepatitis C virus-infected patients for the kidney transplant waiting list

21 January 2018

1 reference

Long-term effect of hepatitis C virus chronic infection on patient and renal graft survival.

21 January 2018

1 reference

Transjugular liver biopsy in patients with end-stage renal disease.

21 January 2018

1 reference

Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).

21 January 2018

1 reference

APASL consensus statements and management algorithms for hepatitis C virus infection.

21 January 2018

1 reference

Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis

21 January 2018

1 reference

Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients.

21 January 2018

1 reference

Diagnostic accuracy of the fibrotest in hemodialysis and renal transplant patients with chronic hepatitis C virus

21 January 2018

1 reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis

21 January 2018

1 reference

Pretransplant interferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV-RNA clearance

21 January 2018

1 reference

Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation

21 January 2018

1 reference

Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy

21 January 2018

1 reference

Natural history of hepatitis C virus-related liver fibrosis after renal transplantation

21 January 2018

1 reference

Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients.

21 January 2018

1 reference

Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection

21 January 2018

1 reference

Time of acquisition of HCV infection in renal transplant recipients: a major prognostic factor for disease progression

21 January 2018

1 reference

The acquisition time of infection: a determinant of the severity of hepatitis C virus-related liver disease in renal transplant patients

21 January 2018

1 reference

Immunosuppression in hepatitis C virus-infected patients after kidney transplantation

21 January 2018

1 reference

Hepatocellular carcinoma in renal transplant patients

21 January 2018

1 reference

Hepatocellular carcinoma following renal transplantation: experience in northern Taiwan.

21 January 2018

1 reference

Renal disease associated with hepatitis C infection after kidney and liver transplantation

21 January 2018

1 reference

Impact of extrahepatic complications (diabetes and glomerulonephritis) associated with hepatitis C virus infection after renal transplantation

21 January 2018

1 reference

Hepatitis C virus-associated glomerulonephritis.

21 January 2018

1 reference

Hepatitis C virus in patients with cryoglobulinemia type II.

21 January 2018

1 reference

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

21 January 2018

1 reference

Hepatitis C virus infection and de novo glomerular lesions in renal allografts

21 January 2018

1 reference

Hepatitis C virus infection and kidney disease: a meta-analysis

21 January 2018

1 reference

Transplant glomerulopathy: it's not always about chronic rejection.

21 January 2018

1 reference

Advances in the understanding of transplant glomerulopathy

21 January 2018

1 reference

Transplant glomerulopathy: subclinical incidence and association with alloantibody.

21 January 2018

1 reference

Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy

21 January 2018

1 reference

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

21 January 2018

1 reference

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

21 January 2018

1 reference

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

21 January 2018

1 reference

Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study

21 January 2018

1 reference

Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus

21 January 2018

1 reference

Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality

21 January 2018

1 reference

Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: role of hepatitis C infection

21 January 2018

1 reference

Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus

21 January 2018

1 reference

Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies

21 January 2018

1 reference

Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation

21 January 2018

1 reference

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

21 January 2018

1 reference

Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes

21 January 2018

1 reference

Impaired insulin sensitivity as an underlying mechanism linking hepatitis C and posttransplant diabetes mellitus in kidney recipients.

21 January 2018

1 reference

Diabetes and infections-hepatitis C: is there type 2 diabetes excess in hepatitis C infection?

21 January 2018

1 reference

The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure

21 January 2018

1 reference

Impact of hepatitis C virus infection on the risk of infectious complications after kidney transplantation: data from the RESITRA/REIPI cohort.

21 January 2018

1 reference

The impact of hepatitis C virus infection on renal allograft recipients

21 January 2018

1 reference

Rates of first infection following kidney transplant in the United States.

21 January 2018

1 reference

Meta-analysis of observational studies: hepatitis C and survival after renal transplant

21 January 2018

1 reference

Hepatitis C virus, an important risk factor for tuberculosis in immunocompromised: experience with kidney transplantation

21 January 2018

1 reference

Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies

21 January 2018

1 reference

Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies

21 January 2018

1 reference

Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium

21 January 2018

1 reference

Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus

21 January 2018

1 reference

Liver cancer and non-Hodgkin lymphoma in hepatitis C virus-infected patients: results from the DANVIR cohort study

21 January 2018

1 reference

Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy.

21 January 2018

1 reference

Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis

21 January 2018

1 reference

Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities.

21 January 2018

1 reference

Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management

21 January 2018

1 reference

Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry.

21 January 2018

1 reference

Hepatitis C virus related lymphoproliferative disorder in a renal transplant recipient

21 January 2018

1 reference

Trends in kidney transplantation outcome: the Andalusian Kidney Transplant Registry, 1984-2007.

21 January 2018

1 reference

The impact of hepatitis C virus infection on long-term outcome in renal transplant patients

21 January 2018

1 reference

Harmful effects of viral replication in seropositive hepatitis C virus renal transplant recipients

21 January 2018

1 reference

Survival advantage of kidney transplantation over dialysis in patients with hepatitis C: a systematic review and meta-analysis.

21 January 2018

1 reference

Outcomes following renal transplantation in patients with chronic hepatitis C based on severity of fibrosis on pre-transplant liver biopsy

21 January 2018

1 reference

25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end.

21 January 2018

1 reference

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

21 January 2018

1 reference

Emerging therapies for the treatment of hepatitis C

21 January 2018

1 reference

Current and future therapies for hepatitis C virus infection

21 January 2018

1 reference

Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

21 January 2018

1 reference

Sofosbuvir for previously untreated chronic hepatitis C infection

21 January 2018

1 reference

Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy.

21 January 2018

1 reference

Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients

21 January 2018

1 reference

Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients

21 January 2018

1 reference

Pegylated interferon -2a versus standard interferon -2a for treatment-naive dialysis patients with chronic hepatitis C: a randomised study

21 January 2018

1 reference

Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C.

21 January 2018

1 reference

Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta-analysis of clinical trials

21 January 2018

1 reference

Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models

21 January 2018

1 reference

Should ribavirin be used to treat hepatitis C in dialysis patients?

21 January 2018

1 reference

Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials

21 January 2018

1 reference

Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy.

21 January 2018

1 reference

Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial

21 January 2018

1 reference

Anti-viral triple therapy with telaprevir in haemodialysed HCV patients: is it feasible?

21 January 2018

1 reference

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

Pegylated interferon-alpha-based treatment for chronic hepatitis C in renal transplant recipients: an open pilot study.

21 January 2018

1 reference

Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients

21 January 2018

1 reference

Safety and efficacy of peginterferon-α2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis C.

21 January 2018

1 reference

Development and pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a (40 kD).

21 January 2018

1 reference

Treatment of hepatitis C after kidney transplant: a pooled analysis of observational studies

21 January 2018

1 reference

Interferon-based anti-viral therapy for hepatitis C virus infection after renal transplantation: an updated meta-analysis

21 January 2018

1 reference

Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting

21 January 2018

1 reference

Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis C.

21 January 2018

1 reference

Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK).

21 January 2018

1 reference

Simultaneous liver-kidney transplantation summit: current state and future directions.

21 January 2018

1 reference

Recipient survival and graft survival are not diminished by simultaneous liver-kidney transplantation: an analysis of the united network for organ sharing database

21 January 2018

1 reference

Kidney grafts from HCV-positive donors: advantages and disadvantages.

21 January 2018

1 reference

Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients

21 January 2018

1 reference

Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation

21 January 2018

1 reference

Long-term experience with kidney transplantation from hepatitis C-positive donors into hepatitis C-positive recipients

21 January 2018

1 reference

The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience.

21 January 2018

1 reference

Renal transplantation from donors with a positive serology for hepatitis C.

21 January 2018

1 reference

Underutilization of hepatitis C-positive kidneys for hepatitis C-positive recipients.

21 January 2018

1 reference

Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/AJT.12835

1 reference

31 August 2017

1 reference